Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review.

Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse
Meredith SpadaPriya Gopalan

Abstract

Background: Opioid use greatly increases the risk of overdose death, as well as contracting human immunodeficiency virus (HIV) and hepatitis. Opioid agonist treatment is recommended for pregnant women who are dependent on opioids. However, there is a dearth of studies on the use of opioid agonist treatment in pregnant teenagers. Case: Ms. A, a 15 year-old G1PO in foster care, presented to our tertiary women's hospital requesting opioid agonist treatment for use of pill opioids. She reported nasal inhalation of 5-6 opioid tablets daily, with recent attempts to self-taper using nonprescribed buprenorphine since learning of her pregnancy. Last reported opioid use was >24 hours prior to admission. Urine drug testing was positive only for opioids (negative for buprenorphine and methadone). She did not exhibit significant withdrawal symptoms while hospitalized. The psychiatric treatment team recommended deferring opioid agonist treatment and pursuing outpatient substance use treatment. Unfortunately, Ms. A did not attend outpatient treatment and was lost to follow up. Discussion: Based upon our experience and review of the studies regarding opioid use disorder (OUD) and perinatal and adolescent opioid use, we recommend that pregnant ...Continue Reading

References

Jan 1, 1973·The International Journal of the Addictions·G G DeAngelis, W X Lehmann
May 15, 1972·JAMA : the Journal of the American Medical Association·C M Rosenberg, V D Patch
Dec 4, 1971·British Medical Journal·P BoydJ R Crickmay
Oct 6, 2005·Archives of General Psychiatry·Lisa A MarschJohn Brooklyn
Nov 6, 2008·JAMA : the Journal of the American Medical Association·George E WoodyPaul Fudala
Dec 17, 2008·Drug and Alcohol Dependence·Geetha A Subramaniam, Maxine A Stitzer
Jul 25, 2009·Drug and Alcohol Dependence·John M WallaceJohn E Schulenberg
Dec 15, 2010·The New England Journal of Medicine·Hendrée E JonesGabriele Fischer
Sep 2, 2011·Addictive Behaviors·Li-Tzy WuGeorge E Woody
Apr 25, 2012·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Health Care for Underserved Women, UNKNOWN American Society of Addiction Medicine
Jun 5, 2013·Social Work in Public Health·Betty Tai, Nora D Volkow
Jan 27, 2015·Journal of Addiction Medicine·Marjorie C MeyerSarah H Heil
Dec 15, 2015·Drug and Alcohol Dependence·Joseph J PalamarDanielle C Ompad
Jun 22, 2016·Pediatrics·UNKNOWN COMMITTEE ON SUBSTANCE USE AND PREVENTION
Jun 25, 2016·Child and Adolescent Psychiatric Clinics of North America·Bikash SharmaMarc Fishman
Sep 5, 2017·Journal of Substance Abuse Treatment·Hoa T VoMarc Fishman
Dec 18, 2018·The New England Journal of Medicine·Richard MiechMegan E Patrick

❮ Previous
Next ❯

Citations

Jan 10, 2020·Drug and Alcohol Review·Shalini Arunogiri, Suzanne Nielsen

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN
E C Wang
Seminars in Perinatology
Christina E Rodriguez, Kaylin A Klie
Missouri Medicine
Frederick T O'Donnell, Daniel L Jackson
© 2021 Meta ULC. All rights reserved